ABCL - AbCellera Biologics GAAP EPS of -$0.11 beats by $0.01 revenue of $10M misses by $2.21M August, 03 2023 04:47 PM AbCellera Biologics Inc. 2023-08-03 16:47:21 ET AbCellera Biologics press release ( NASDAQ: ABCL ): Q2 GAAP EPS of -$0.11 beats by $0.01 . Revenue of $10M (-78.1% Y/Y) misses by $2.21M . For further details see: AbCellera Biologics GAAP EPS of -$0.11 beats by $0.01, revenue of $10M misses by $2.21M